|
| Kaiser study results on ranibizumab and bevacizumab
| | February 4, 2010 | A Kaiser Permanents Southern California study published in this month?s Ophthalmology, the journal of the American Academy of Ophthalmology, compares ranibizumab (Lucentis) and bevacizumab (Avastin) and found them to be equally effective in halting vision loss. |
| | Stem cell therapy to treat LSCD
| | January 27, 2010 | | Successful limbal stem cell deficiency (LSCD) treatment in eight patients using their own stem cells without immunity suppression has been reported by scientists at the North East England Stem Cell Institute (NESCI). |
| | Eye test could help detect signs of Alzheimer's
| | January 27, 2010 | | Research published in the journal Cell Death and Disease by University College of London scientists indicates that a simple eye test may, in future, be able to detect Alzheimer's, amongst other diseases. |
| | Zeiss to get new CEO
| | January 27, 2010 | | Carl Zeiss's current CEO, Dr Michael Kaschke, has resigned his position on the company?s Management Board. |
| | Presbia strengthens its surgical team
| | January 27, 2010 | | Presbia , which develops and markets a surgical solution for presbyopia has appointed ophthalmic surgeons Dr Jorge L. Alio of Madrid, Spain (an OTEurope editorial advisory board member) and Dr Kerry K. Assil of California, have agreed to serve on its Medical Advisory Board. |
|
| |
| |
|  | | Retina
| | Glaucoma
| | Strabismus
| | Cataract & Refractive
| | Cornea
| |
| | |
|  | | Retina
| | General
| | Cataract & Refractive
| | Glaucoma
| |
| |
|
 |  |  |  | | |  | | Ophthalmology Times Europe is the independent source for current developments and best practices in European Ophthalmology. It is the balanced and unbiased forum for ophthalmologists to communicate practical experience, clinical knowledge, discoveries and applications, thereby promoting improvements in medical medical practice and patient health.
Serving Europe's ophthalmic community |
|
|
| | |  | |  | |
| 
